Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Clin Chim Acta. 2009 Apr;402(1-2):189–192. doi: 10.1016/j.cca.2009.01.011

Table 2.

Estimated effects for polymorphisms selected in risk factor-adjusted analyses.

Gene symbol and dbSNP rs number MAF Cox regression (HR; 95%CI; p)

additive dominant
ACE rs1799752 0.445 1.35; 0.88–2.05; 0.17 1.83, 0.88–3.86, 0.11
ADD1 rs4961 0.208 0.73; 0.40–1.32; 0.29 0.70, 0.36–1.36, 0.30
ADRB2 rs1042713 0.382 0.89; 0.60–1.40; 0.63 1.09, 0.58–2.07, 0.78
ADRB2 rs1042714 0.423 1.37; 0.90–2.09; 0.14 1.69, 0.80–3.56, 0.17
ADRB3 rs4994 0.066 0.31; 0.15–1.36; 0.13 0.34, 0.08–1.40, 0.13
AGTR1 rs5186 0.255 0.97; 0.60–1.59; 0.91 0.97, 0.52–1.82, 0.93
AGT rs699 0.438 1.28; 0.81–2.00; 0.29 1.25, 0.81–2.57, 0.54
APOA4 rs675 0.184 0.97; 0.55–1.72; 0.91 0.90, 0.46–1.78, 0.76
APOA4 rs5110 0.068 1.24; 0.54–2.87; 0.62 1.31, 0.55–3.14, 0.54
APOB rs1367117 0.314 0.85; 0.52–1.40; 0.53 0.77, 0.41–1.44, 0.41
APOC3 rs2542052 0.382 1.03; 0.67–1.59; 0.89 1.01, 0.53–1.92, 0.97
APOC3 rs2854117 0.251 0.91; 0.55–1.51; 0.72 0.96, 0.51–1.80, 0.89
APOC3 rs2854116 0.368 1.10; 0.71–1.70; 0.68 1.10, 0.58–2.09, 0.78
APOC3 rs4520 0.266 1.11; 0.70–1.78; 0.66 0.93, 0.49–1.76, 0.83
APOC3 rs5128 0.098 0.76; 0.33–1.74; 0.51 0.63, 0.25–1.62, 0.34
APOC3 rs4225 0.368 1.05; 0.67–1.65; 0.83 0.88, 0.46–1.66, 0.68
APOE rs429358 0.135 1.05; 0.57–1.93; 0.87 1.08, 0.54–2.17, 0.83
APOE rs7412 0.088 1.06; 0.47–2.40; 0.89 1.06, 0.47–2.40, 0.89
C3 rs2230199 0.256 0.82; 0.49–1.36; 0.44 0.92, 0.49–1.72, 0.79
C5 rs17611 0.435 1.03; 0.64–1.66; 0.90 1.24, 0.60–2.55, 0.56
CCL11 rs4795895 0.183 1.38; 0.80–2.38; 0.24 1.66, 0.89–3.10, 0.11
CCL11 rs3744508 0.183 0.55; 0.28–1.09; 0.09 0.49, 0.22–1.06, 0.07
CCR2 rs1799864 0.088 2.00; 1.15–3.48; 0.014 2.50, 1.26–4.94, 0.008
CCR5 rs333 0.089 0.97; 0.43–2.21; 0.95 1.04, 0.43–2.48, 0.93
CCR5 rs1799987 0.457 0.93; 0.61–1.42; 0.75 0.91, 0.47–1.76, 0.77
CD14 rs2569190 0.448 0.93; 0.60–1.44; 0.75 0.79, 0.42–1.50, 0.47
CETP rs1800775 0.496 0.63; 0.40–0.98; 0.041 0.54, 0.28–1.04, 0.07
CETP rs5882 0.306 1.30; 0.82–2.06; 0.27 1.02, 0.54–1.91, 0.96
CETP rs708272 0.453 1.48; 0.96–2.29; 0.07 1.68, 0.80–3.55, 0.17
CSF2 rs25882 0.201 0.75; 0.41–1.38; 0.36 0.74, 0.37–1.48, 0.39
CTLA4 rs5742909 0.125 0.91; 0.45–1.86; 0.80 0.95, 0.45–1.99, 0.88
CTLA4 rs231775 0.368 0.82; 0.50–1.33; 0.42 0.70, 0.37–1.30, 0.26
F5 rs6025 0.137 1.13; 0.60–2.11; 0.71 1.07, 0.55–2.10, 0.84
F7 rs5742910 0.121 1.63; 0.93–2.88; 0.09 1.73, 0.91–3.31, 0.10
F7 rs6046 0.108 1.79; 0.99–3.23; 0.06 1.82, 0.94–3.51, 0.08
GC rs7041 0.447 1.56; 0.98–2.48; 0.06 1.35, 0.64–2.84, 0.43
GC rs4588 0.297 1.38; 0.87–2.21; 0.17 1.10, 0.58–2.08, 0.76
GNB3 rs5443 0.318 0.70; 0.42–1.18; 0.18 0.54, 0.29–1.02, 0.06
ICAM1 rs1799969 0.112 1.21; 0.62–2.38; 0.58 0.98, 0.45–2.14, 0.96
LDLR rs5742911 0.317 0.92; 0.58–1.46; 0.72 0.97, 0.51–1.84, 0.93
IL1A rs1800587 0.340 0.99; 0.60–1.63; 0.95 1.04, 0.54–1.98, 0.90
IL1B rs16944 0.350 0.92; 0.55–1.52; 0.74 1.05, 0.55–2.02, 0.87
IL1B rs1143634 0.229 1.06; 0.65–1.72; 0.83 1.10, 0.59–2.07, 0.76
IL4 rs2243250 0.165 0.76; 0.41–1.44; 0.40 0.73, 0.35–1.49, 0.38
IL4R rs1801275 0.201 0.93; 0.54–1.58; 0.78 0.82, 0.42–1.59, 0.56
IL4R rs1805015 0.166 1.04; 0.59–1.86; 0.88 0.86, 0.43–1.72, 0.66
IL5RA rs2290608 0.303 1.01; 0.61–1.70; 0.96 1.20, 0.63–2.25, 0.58
IL6 rs1800796 0.074 1.72; 0.87–3.40; 0.12 1.78, 0.88–3.59, 0.11
IL6 rs1800795 0.392 0.86; 0.54–1.37; 0.53 0.76, 0.40–1.44, 0.40
IL9 rs2069885 0.175 1.16; 0.66–2.02; 0.61 1.00, 0.50–1.96, 0.99
IL13 rs1295686 0.205 1.17; 0.70–1.96; 0.55 1.24, 0.66–2.35, 0.50
ITGA2 rs1062535 0.399 0.74; 0.47–1.16; 0.19 0.63, 0.34–1.17, 0.14
ITGB3 rs5918 0.140 0.92; 0.48–1.75; 0.80 0.87, 0.43–1.78, 0.71
LIPC rs1800588 0.223 1.13; 0.70–1.84; 0.61 1.22, 0.65–2.30, 0.54
LPA rs1853021 0.182 0.97; 0.56–1.70; 0.92 0.73, 0.35–1.50, 0.39
LPA rs1800769 0.164 0.75; 0.38–1.49; 0.41 0.70, 0.32–1.53, 0.37
LPL rs328 0.111 1.16; 0.59–2.28; 0.67 1.09, 0.52–2.31, 0.82
LTA rs1041981 0.343 1.08; 0.72–1.65; 0.70 1.02, 0.55–1.89, 0.95
LTA rs909253 0.344 1.18; 0.73–1.92; 0.51 1.16, 0.61–2.20, 0.66
LTC4S rs730012 0.271 0.96; 0.57–1.59; 0.87 0.83, 0.45–1.56, 0.57
MMP3 rs3025058 0.476 1.66; 1.10–2.49; 0.015 6.87, 2.12–22.30, 0.001
MTHFR rs1801133 0.319 1.26; 0.80–1.98; 0.31 1.12, 0.60–2.08, 0.72
NOS2A rs1137933 0.234 1.01; 0.59–1.75; 0.97 0.87, 0.46–1.64, 0.66
NOS3 rs1800779 0.379 0.85; 0.53–1.35; 0.49 0.79, 0.42–1.48, 0.47
NOS3 rs3918226 0.073 0.89; 0.36–2.22; 0.80 0.91, 0.36–2.33, 0.85
NOS3 rs1799983 0.308 0.82; 0.50–1.37; 0.45 0.70, 0.37–1.30, 0.25
NPPA rs5065 0.161 1.05; 0.60–1.82; 0.88 1.11, 0.58–2.13, 0.74
PON1 rs854560 0.375 0.83; 0.52–1.33; 0.44 1.11, 0.58–2.11, 0.76
PON1 rs662 0.274 1.79; 1.08–2.95; 0.023 1.78, 0.92–3.43, 0.08
PON2 rs695435 0.216 1.56; 0.96–2.54; 0.07 1.62, 0.86–3.04, 0.14
PPARG rs1801282 0.124 1.32; 0.67–2.59; 0.42 1.38, 0.69–2.79, 0.36
SCGB1A1 rs3741240 0.318 1.02; 0.64–1.63; 0.93 0.90, 0.48–1.68, 0.74
SCNN1A rs2228576 0.257 0.67; 0.38–1.18; 0.17 0.60, 0.31–1.18, 0.14
SDF1 rs1801157 0.213 0.75; 0.40–1.37; 0.35 0.72, 0.36–1.42, 0.34
SELE rs5361 0.124 0.71; 0.33–1.54; 0.39 0.74, 0.32–1.66, 0.46
SELP rs6133 0.118 1.06; 0.55–2.05; 0.86 1.08, 0.49–2.34, 0.85
SELP rs6131 0.212 1.35; 0.83–2.20; 0.22 1.78, 0.95–3.31, 0.07
SERPINE1 rs1799768 0.542 0.84; 0.55–1.28; 0.42 0.95, 0.46–1.94, 0.89
SERPINE1 rs7242 0.413 0.83; 0.52–1.32; 0.43 0.87, 0.46–1.63, 0.66
TCF7 rs244656 0.142 1.00; 0.51–1.96; 1.00 0.94, 0.45–2.00, 0.88
TCF7 rs5742913 0.116 1.59; 0.83–3.03; 0.16 1.64, 0.85–3.19, 0.14
TGFB1 rs1800469 0.312 1.08; 0.69–1.70; 0.73 1.36, 0.72–2.56, 0.34
TNF rs1800629 0.177 0.72; 0.38–1.35; 0.30 0.77, 0.38–1.54, 0.46
TNF rs361525 0.075 0.71; 0.26–1.95; 0.50 0.72, 0.26–2.03, 0.53
VDR rs2228570 0.420 1.03; 0.66–1.59; 0.91 1.09, 0.56–2.12, 0.80
VDR rs1544410 0.417 1.23; 0.78–1.94; 0.36 1.25, 0.64–2.47, 0.51

MAF, minor allele frequency; HR, hazard ratio; CI, confidence interval.

Significant results (uncorrected) from Cox regression analysis are in boldface.